Stool cultures obtained before liver transplantation are useful for choice of perioperative antibiotic: Prophylaxis

Transplant International

Volumn 10, Issue 6, 1997, Pages 432-438

  Barkholt, L M ^a   Andersson, J ^a   Ericzon, B G ^a   Palmgren, A C ^a   Broome U ^a   Duraj, F ^a   Bergquist, A ^a   Herlenius, G ^a   Nord, C E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Liver transplantation, stool cultures, antibiotic prophylaxis Antibiotic prophylaxis, liver transplantation, stool cultures; Stool cultures, liver transplantation, antibiotic prophylaxis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZATHIOPRINE; CEFOTAXIME; CYCLOSPORIN A; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; OKT 3; STEROID; TACROLIMUS; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CHOLANGITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; FECES CULTURE; FEMALE; GRAFT FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; URINE CULTURE;

ADULT; AMPICILLIN; AMPICILLIN RESISTANCE; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CHOLANGITIS; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, MULTIPLE; ENTEROBACTERIACEAE; FECES; FEMALE; FEVER; GENTAMICINS; HUMANS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0030734292     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050082     Document Type: Article

References (39)

1. Antalek MD, Mylotte JM, Lesse AJ, Sellick JA Jr (1995) Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin. Clin Infect Dis 20: 103-109
2. Barkholt LM, Ericzon B-G, Tollemar J, Malmborg A-S, Ehrnst A, Wilczek H, Andersson J (1993) Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int 6: 77-84
3. Brettschneider L, Tong JL, Boose DS, Daloze PM, Smith GV, Huguet C, Blanchard H, Groth CG, Starzl TE (1968) Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg 97: 313-322
4. Colonna JO, Winston DJ, Brill JE, Goldstein LI, Hoff MP, Hiatt JR, Quinones-Baldrich W, Ramming KP, Busuttil RW (1988) Infectious complications in liver transplantation. Arch Surg 123: 360-364
5. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP (1995) Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 20: 1126-1133
6. Ehrnst A, Barkholt L, Lewensohn-Fuchs I, Ljungman P, Teodosiu O, Staland Å, Ringdén O, Tydén G, Johansson B (1995) CMV PCR monitoring in leucocytes of transplant patients. Clin Diagn Virol 3: 139-153
7. Elinder CG, Andersson J, Bounder G, Tydén G (1992) Effectiveness of lowdose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation. Transpl Int 5: 81-84
8. George DL, Arnow PM, Fox AS (1991) Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 13: 387-396
9. Green M, Shlaes JH, Barbadora K, Shlaes DM (1995) Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis 20: 712-714
10. Hadley S, Samore HM, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM (1995) Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporin or FK506 as primary immunosuppression. Transplantation 59: 851-859
11. Heimdahl A, Nord CE (1979) Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 11:233-242
12. Heurlin N, Brattström C, Lönnqvist B, Westman L, Lidman C, Andersson J (1991) Aetiology of pulmonary disease in immunocompromised patients. Eur Respir J 4: 10-18
13. Howard TK, Klintmalm GBG, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA (1990) The influence of preservation injury on rejection in the hepatic transplant recipients. Transplantation 49: 103-107
14. Johnson AP (1994) The pathogenicity of enterococci. J Antimicrob Chemother 33: 1083-1089
15. Kibbler CC (1995) Infections in liver transplantation: risk factors and strategies for prevention J Hosp Infect 30 [Suppl]: 209-217
16. Kobota K, Ericzon B-G, Barkholt L, Reinholt FP (1992) The correlation between cytological pattern in bile and histological findings in liver transplantation. Transplantation 53: 791-795
17. Kusne S, Dummer JS, Sing N, Iwatsuki S, Makowka L, Esquivel C, Tzakis AF, Starzl TE, Ho M (1988) Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 67: 132-143
18. Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, Kusne S (1996) Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 22: 663-670
19. Lyerly DM (1988) Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1: 1-18
20. Murray BE (1990) The life and times of the enterococcus. Clin Microbiol Rev 3: 46-65
21. Noskin GA, Peterson LR, Warren JR (1995) Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 20: 296-301
22. Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F (1993) Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia: a matched case-control study. Arch Intern Med 153: 1581-1586
23. Papanicolaou GA, Meyers BR, Meyers J, Mendelson MH, Lou W, Emre S, Scheiner P, Miller C (1996) Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 23: 760-766
24. Patel R, Badley AD, Larson-Keller J, Harmsen WS, Ilstrup DM, Wiesner RH, Steers JL, Krom RAF, Portela D, Cockerill FR, Paya CV (1996) Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 61: 1192-1197
25. Paya CV, Hermans PE, Washington JA II, Smith TF. Anhalt JP, Weisner RH, Krom RAF (1989) Incidence, distribution and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 64: 555-564
26. Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom RA. Rettke S, Smith TF (1993) Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation. J Hepatol 18: 185-195
27. Pechére JC (1992) In vitro activity of RP5900 a semisynthetic streptogramin against staphylococci and streptococci. J Antimicrob Chemother 30 [Suppl A]: S15-18
28. Pepys MB (1988) Amyloidosis. In: Samter M, Talmage DW, Frank MM, Austen KF, Claman GN (eds) Immunological diseases, 4th edn, vol 1. Little Brown. Boston, pp 6731-6734
29. Rubin RH (1994) Infection in the organ transplant recipient. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 3rd edn. Plenum Medical, New York, pp 629-705
30. Starzl TE, Shunzaburo I, Esquivel CO, Todo S, Kam I, Lynch S, Gordon RD, Shaw BW Jr (1985) Refinements in the surgical techniques of liver transplantation. Semin Liver Dis 5: 349-356
31. Starzl TE, Shunzaburo I, Shaw BW, Gordon RD, Esquivel CO (1985) Immunosuppression and other nonsurgical factors in the improved results of liver transplantations. Semin Liver Dis 5: 334-343
32. Tollemar J, Ericzon B-G (1991) Invasive Candida albicans infection in orthotopic liver graft recipients. Incidence and risk factors. Clin Transplant 5: 306-312
33. Triger DR, Wright R (1985) Immunological aspects of liver disease. In: Wright R, Millward-Sadler GH, Alberti KGMM, Karran S (eds) Liver and biliary disease, 2nd edn. Bailliére Tindall, London, pp 215-231
34. Truelove SC, Watkinson G, Draper G (1962) Comparison of corticosteroids and sulphasalazine therapy in ulcerative colitis, BMJ 2: 1708-1711
35. United Network for Organ Sharing (1993) Annual report of the U. S. Registry for Transplant Recipients and the Organ Procurement and Transplantation Network. United Network for Organ Sharing, Richmond VA, and the Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U. S. Department of Health and Human Services, Bethesda, MD
36. Wade JJ (1997) Enterococcus faecium in hospitals. Eur J Clin Microbiol Infect Dis 16: 113-119
37. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R (1995) Bacterial and fungal infections in liver transplantation. An analysis of 284 patients. Hepatology 21: 1328-1336
38. Winston DJ, Emmanouilides C, Busuttil RW (1995) Infections in liver transplant recipients. Clin Infect Dis 21: 1077-1091
39. Zimmermann RA, Moeöeromg RC Jr, Weinberg AN (1971) Mechanism of resistance to antibiotic synergism in enterococci. J Bacteriol 105: 873-879